Tools
Programs
Blood
A healthy blood system is essential to all human life. We are investigating what constitutes a healthy blood system and diligently working on improving bone marrow and cord blood transplants. These blood products are important to all oncology programs. Blood transfusion products are required in routine cancer treatment to support chemotherapy regimens and bone marrow transplantation is the only curative procedure for eligible patients with leukemia.
Principal Investigators
Related Projects
To develop cell-based tools for use in drug screening of patient-specific stem cells.
To identify novel therapeutics that can target the bone marrow environment to destroy and prevent leukemia. By better understanding the optimal bone marrow conditions needed to support healthy blood stem cells, this study also has the potential to improve stem cell transplantation therapies.
The combination of standard of care chemotherapy, coupled with novel drugs discovered by our group, is hoped to prevent cancer relapse.
Related News
SCCRI uncovers unexpected cells responsible for leukemia relapse, offering new leads for therapy
The Bhatia Lab has characterised the process of how leukemia cells initially respond to treatment but retaliate after chemotherapy. Findings help predict the risk of disease recurrence and can be therapeutically used to prevent relapse. [...]
Lili Aslostovar | Wednesday, September 12, 2018
New insights made into blood stem cell control
Dr. Kristin Hope's team, in collaboration with efforts from Dr. Jon Draper's lab, have discovered two new regulators of the gene Musashi-2, a key protein that promotes the regenerative capacity of blood stem cells. [...]
Darlene Lane | Tuesday, April 10, 2018
Canadian Cancer Society's Daffodil Campaign and CHCH's Interview with Mick Bhatia
To kick off Daffodil Month, CHCH News visited the SCC-RI to learn about research and how it is impacting patient care in Hamilton. We reflect back on that interview. [...]
Darlene Lane | Tuesday, April 10, 2018